Asston Pharmaceuticals Approves Key Appointments, Auditor Change, and Remuneration Hikes at AGM
Asston Pharmaceuticals Ltd 路 Change in Management 路 01 Oct 2026, 7:33 pm
Asston Pharmaceuticals Approves Key Appointments, Auditor Change, and Remuneration Hikes at AGM Asston Pharmaceuticals shareholders approved key resolutions at the AGM on 29th Sep'26. Members adopted the audited standalone financial statements for the fiscal ended 31st Mar'26 and approved the re-appointment of Managing Director Ashish Narayan Sakalkar, retiring by rotation. The company appointed M/s Panchal S K & Associates as Statutory Auditors. Additionally, shareholders approved remuneration increases for MD Ashish Narayan Sakalkar, Whole-time Director & CEO Saili Jayaram More, and Non-Executive Director Sachin Chandrakant Badakh.
Original exchange filing (PDF)
More announcements from Asston Pharmaceuticals Ltd
- Unaudited Financial Results for the Half Year ended 30 September, 2026 with Limited Review Report. 路 12 Nov 2026
- Outcome of the Board Meeting 路 12 Nov 2026
- Asston Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 ,inter alia, to consider and approve the Unaudited Financial .... 路 12 Nov 2026
- Change in registered office address 路 13 Oct 2026
- Outcome of the Board held on 13th October, 2026. 路 13 Oct 2026
- Asston Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/10/2026 ,inter alia, to consider and approve matters as attached 路 06 Oct 2026
- Appointment of Statutory Auditor of the Company 路 01 Oct 2026
- Scrutinizer Report 路 01 Oct 2026
